CWC
TMO icon

Carolinas Wealth Consulting’s Thermo Fisher Scientific TMO Stock Holding History

Carolinas Wealth Consulting’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-414
Closed -$206K – 853
2025
Q1 		$206K Buy
414
+2
+0.5% +$1.08K 0.04% 174
2024
Q4 		$214K Sell
412
-3
-0.7% -$1.65K 0.04% 179
2024
Q3 		$257K Sell
415
-16
-4% -$9.47K 0.05% 162
2024
Q2 		$238K Sell
431
-183
-30% -$105K 0.05% 164
2024
Q1 		$357K Buy
614
+249
+68% +$140K 0.07% 124
2023
Q4 		$194K Buy
365
+85
+30% +$41.1K 0.04% 164
2023
Q3 		$125K Sell
280
-48
-15% -$25.6K 0.03% 196
2023
Q2 		$171K Buy
328
+40
+14% +$21.6K 0.03% 186
2023
Q1 		$166K Sell
288
-8
-3% -$4.51K 0.04% 190
2022
Q4 		$163K Buy
296
+196
+196% +$104K 0.04% 190
2022
Q3 		$51K Sell
100
-18
-15% -$10.1K 0.01% 321
2022
Q2 		$64K Buy
118
+4
+4% +$2.2K 0.02% 304
2022
Q1 		$67K Sell
114
-4
-3% -$2.3K 0.01% 309
2021
Q4 		$79K Buy
118
+4
+4% +$2.5K 0.02% 295
2021
Q3 		$65K Buy
114
+1
+0.9% +$549 0.02% 301
2021
Q2 		$57K Buy
113
+33
+41% +$15.6K 0.01% 348
2021
Q1 		$37K Buy
80
+20
+33% +$9.55K 0.01% 413
2020
Q4 		$28K Sell
60
-135
-69% -$63.3K 0.01% 426
2020
Q3 		$86K Buy
195
+179
+1,119% +$74K 0.03% 214
2020
Q2 		$6K Buy
+16
New +$5.36K ﹤0.01% 384

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Carolinas Wealth Consulting's TMO Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 414 shares — an estimated $206K sold.

Carolinas Wealth Consulting first reported a position in TMO in Q2 2020 and held it in 20 quarters. The position peaked at $357K in Q1 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 414 Thermo Fisher Scientific shares in Q2 2025, an estimated $206K.
  • Carolinas Wealth Consulting first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Thermo Fisher Scientific position peaked at $357K in Q1 2024.
  • 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.